IBNYX
Price
$24.13
Change
-$0.12 (-0.49%)
Updated
Nov 12 closing price
RLBGX
Price
$36.70
Change
-$0.23 (-0.62%)
Updated
Nov 12 closing price
Ad is loading...

IBNYX vs RLBGX

Header iconIBNYX vs RLBGX Comparison
Open Charts IBNYX vs RLBGXBanner chart's image
Delaware Ivy Balanced Fund
Price$24.13
Change-$0.12 (-0.49%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R6
Price$36.70
Change-$0.23 (-0.62%)
VolumeN/A
CapitalizationN/A
IBNYX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IBNYX vs. RLBGX commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBNYX is a Buy and RLBGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 241B vs. IBNYX (1.6B). RLBGX pays higher dividends than IBNYX: RLBGX (2.55) vs IBNYX (2.06). IBNYX was incepted earlier than RLBGX: IBNYX (21 years) vs RLBGX (16 years). RLBGX is a more actively managed with annual turnover of: 171.00 vs. IBNYX (82.00). IBNYX has a lower initial minimum investment than RLBGX: IBNYX (0) vs RLBGX (250). IBNYX annual gain was more profitable for investors over the last year : 29.03 vs. RLBGX (25.88). RLBGX return over 5 years is better than : 40.79 vs. IBNYX (0.88).
IBNYXRLBGXIBNYX / RLBGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years16 years-
Gain YTD19.06116.789114%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.6B241B1%
Annual Yield % from dividends2.062.5581%
Returns for 1 year29.0325.88112%
Returns for 3 years-17.1813.60-126%
Returns for 5 years0.8840.792%
Returns for 10 years2.6757.255%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVEE23.740.39
+1.67%
NV5 Global Inc
CNI111.640.84
+0.76%
Canadian National Railway
REYN27.550.11
+0.40%
Reynolds Consumer Products
ELTX5.03-0.05
-0.94%
Elicio Therapeutics
NEXN7.65-0.25
-3.11%
Nexxen International Ltd